Aarhus University Seal / Aarhus Universitets segl

Apolipoprotein M and Risk of Type 2 Diabetes

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review


  • Stefan Hajny, University of Copenhagen
  • ,
  • Mette Christoffersen, University of Copenhagen
  • ,
  • Nawar Dalila, University of Copenhagen
  • ,
  • Lars B. Nielsen
  • ,
  • Anne Tybjærg-Hansen, University of Copenhagen
  • ,
  • Christina Christoffersen, University of Copenhagen

Context: Recent studies have discovered a role of apolipoprotein M (apoM) in energy metabolism, and observational analyses in humans suggest an association with type 2 diabetes. The causal relationship remains however elusive. Objective: To investigate whether reduced plasma apoM concentrations are causally linked to increased risk of type 2 diabetes. Design: Prospective study design analyzed by Mendelian randomization. Setting and participants: Two cohorts reflecting the Danish general population: the Copenhagen City Heart Study (CCHS, n = 8589) and the Copenhagen General Population Study (CGPS; n = 93 857). Observational analyses included a subset of participants from the CCHS with available plasma apoM (n = 725). Genetic analyses included the complete cohorts (n = 102 446). During a median follow-up of 16 years (CCHS) and 8 years (CGPS), 563 and 2132 participants developed type 2 diabetes. Main outcome measures: Plasma apoM concentration, genetic variants in APOM, and type 2 diabetes. Results: First, we identified an inverse correlation between plasma apoM and risk of type 2 diabetes in a subset of participants from the CCHS (hazard ratio between highest vs lowest quartile (reference) = 0.32; 95% confidence interval = 0.1-1.01; P for trend = .02). Second, genotyping of specific single nucleotide polymorphisms in APOM further revealed a 10.8% (P = 6.2 × 10–5) reduced plasma apoM concentration in participants with variant rs1266078. Third, a meta-analysis including data from 599 451 individuals showed no association between rs1266078 and risk of type 2 diabetes. Conclusions: The present study does not appear to support a causal association between plasma apoM and risk of type 2 diabetes.

Original languageEnglish
JournalJournal of Clinical Endocrinology and Metabolism
Pages (from-to)3046-3057
Number of pages12
Publication statusPublished - Sep 2020

Bibliographical note

Publisher Copyright:
© endocrine society 2020. all rights reserved.

Copyright 2021 Elsevier B.V., All rights reserved.

    Research areas

  • Apolipoproteins, Genetics, Mendelian randomization, Type 2 diabetes

See relations at Aarhus University Citationformats

ID: 217224463